CIK 0001626878 · Non-accelerated filer<br>Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 4 Open-market buy 10% owner bought 16,426 shares at $7.91 ($129,930)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $10.00 ($45,000)
- 4/A Open-market buy Director bought 44,838 shares at an average $5.52 ($247,369)
- 4 Open-market buy 10% owner bought 45,574 shares at an average $8.14 ($370,835)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 112,300 shares at an average $9.25 ($1,039,049)
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 29,802 shares at an average $5.73 ($170,799)
- 4 Option exercise Chief Executive Officer acquired 50,000 shares (option exercise)
- 4 Open-market buy Director bought 2,900 shares at an average $3.74 ($10,842)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
Page 11 of 21 · 408 filings